Vanessa's Comment:

 Very interesting approach. This pilot study of 12 patients achieved median progression-free survival of 9.1 months and median overall survival of 17.6 months. Four of the 12 (33%) patients have survived more than two years, with the longest surviving patient currently out to 60 months. Looking forward to seeing a larger phase 2 study!

---

Posted on: 04/28/2024

Results from a first-in-human phase I safety trial to evaluate the use of a vascularized pericranial/temporoparietal fascial flap to line the resection cavity following resection of newly diagnosed glioblastoma

 

---

Click HERE to return to brain tumor news headlines.